It remains to be seen if the proposed mechanism also applies to other types of cancer in which FOXQ1 may act as a tumour suppressor, such as HER2-positive breast cancer [35], or whether it is specific to melanomas. This evidence concerns the gene ERBB2 and neoplasm.